Other
Novartis Q4 net profit rises to $2.0 billion
Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
Jan 29, 2014
0
0
News tagged with generic competition
Other
Pfizer's 4Q net plunges on charges, sales decline
Drugmaker Pfizer said Tuesday that fourth-quarter profit plunged 59 percent because of discontinued operations, restructuring and other charges, and generic competition continuing to siphon off revenue from former blockbuster ...
Jan 28, 2014
0
0
Medications
Pfizer, Teva reach deal to allow generic Viagra
Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.
Dec 17, 2013
0
0
Other
Pfizer 3Q net falls due to generics, higher costs
Pfizer Inc.'s third-quarter profit dropped 19 percent as competition from generic drugs continued to cut sales, while lower operating expenses failed to offset higher taxes and charges.
Oct 29, 2013
0
0
Other
Merck 3Q net income falls on charges, lower sales
Merck & Co. said Monday that its third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges. It still beat Wall Street's ...
Oct 28, 2013
0
0
Medications
Economists throw doubt on generic drug price advantage over branded version
(Medical Xpress)—People given a choice between generic or branded drugs should look closely at the ingredients in the drug they are buying, argue economists from Deakin University's Graduate School of Business.
Sep 16, 2013
0
0
HIV & AIDS
Patents making new AIDS drugs expensive, MSF says
New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.
Jul 2, 2013
2
0
Other
AstraZeneca to pay about $260M for Omthera Pharma (Update 2)
British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees but has a potential treatment for patients who have high levels of fats ...
May 28, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Medications
US Justice Department appeals morning-after case
(AP)—The Obama administration appealed a federal judge's order to lift all age limits on who can buy morning-after birth control pills without a prescription. In appealing the ruling on Wednesday, the administration recommitted ...
May 2, 2013
0
0
